Departamento de Química, Universidade Federal de São Carlos, CP 676, CEP 13565-905 São Carlos, SP, Brazil.
J Inorg Biochem. 2010 May;104(5):489-95. doi: 10.1016/j.jinorgbio.2009.12.015. Epub 2010 Jan 4.
The synthesis and characterization of ruthenium compounds of the type [RuCl(2)(NO)(dppp)(L)]PF(6) [dppp=1,3-bis(diphenylphosphino)propane; L=pyridine, 4-methylpyridine, 4-phenylpyridine and dimethyl sulfoxide] are described. The complexes were characterized by elemental analysis, UV/Vis and infrared spectroscopy, cyclic voltammetry, and X-ray crystallography for the complexes with the pyridine and 4-methylpyridine ligands. In vitro evaluation of these nitrosyl complexes revealed cytotoxic activity from 7.1 to 19.0 microM against the MDA-MB-231 breast tumor cells and showed that, in this case, they are more active than the reference metallodrug cisplatin. The 1,3-bis(diphenylphosphino)propane and the N-heterocyclic ligands alone failed to show cytotoxic activities at the concentrations tested (maximum concentration utilized=200 microM).
描述了 [RuCl(2)(NO)(dppp)(L)]PF(6) [dppp=1,3-双(二苯基膦基)丙烷;L=吡啶、4-甲基吡啶、4-苯基吡啶和二甲亚砜] 类型的钌化合物的合成和表征。这些配合物通过元素分析、紫外可见和红外光谱、循环伏安法以及具有吡啶和 4-甲基吡啶配体的配合物的 X 射线晶体学进行了表征。对这些亚硝酰配合物的体外评价表明,它们对 MDA-MB-231 乳腺癌细胞具有 7.1 至 19.0 μM 的细胞毒性活性,并且表明在这种情况下,它们比参考金属药物顺铂更具活性。在测试的浓度下(最大使用浓度=200 μM),1,3-双(二苯基膦基)丙烷和 N-杂环配体本身没有显示出细胞毒性活性。